Commentary: Accepting what we don't know will lead to progress.

ized clinical trials. J Clin Epidemiol 2002;55:407–10. 24. Ioannidis JP. A generalized view of self-citation: direct, co-author, collaborative, and coercive induced self-citation. J Psychosom Res 2015;78:7–11. 25. Nieminen P, Rucker G, Miettunen J, Carpenter J, Schumacher M. Statistically significant papers in psychiatry were cited more often than others. J Clin Epidemiol 2007;60:939–46. 26. Etter JF, Stapleton J. Citations to trials of nicotine replacement therapy were biased toward positive results and high-impactfactor journals. J Clin Epidemiol 2009;62:831–37. 27. Perino AC, Hoang DD, Holmes TH et al. Association between success rate and citation count of studies of radiofrequency catheter ablation for atrial fibrillation: possible evidence of citation bias. Circ Cardiovasc Qual Outcomes 2014;7:687–92. 28. West R, Stenius K. To cite or not to cite? Use and abuse of citations. In: Babor T, Stenius K, Savva S, O’Reilly J, (eds). Publishing Addiction Science: A Guide for the Perplexed. 2nd edn. Brentwood, UK: Multi-Science Publishing Company, 2008. 29. Atkinson RL, Macdonald I. White hat bias: the need for authors to have the spin stop with them. Int J Obes (Lond) 2010;34:83. 30. Brown AW, Ioannidis JP, Cope MB, Bier DM, Allison DB. Unscientific beliefs about scientific topics in nutrition. Adv Nutr 2014;5:563–65. 31. Cobb LK, Anderson CA, Elliott P et al. Methodological issues in cohort studies that relate sodium intake to cardiovascular disease outcomes: a science advisory from the American Heart Association. Circulation 2014;129:1173–86. 32. Bayer R. Restricting dietary salt and public health: is the evidentiary foundation crumbling? Milbank Q 2014;92:659–61. 33. Elliott KC, Resnik DB. Science, policy, and the transparency of values. Environ Health Perspect 2014;122:647–50. 34. Barnes DE, Bero LA. Why review articles on the health effects of passive smoking reach different conclusions. JAMA 1998;279: 1566–70. 35. Stelfox HT, Chua G, O’Rourke K, Detsky AS. Conflict of interest in the debate over calcium-channel antagonists. N Engl J Med 1998;338:101–06. 36. Rothman DJ. Consequences of industry relationships for public health and medicine. Am J Public Health 2012;102:55. 37. Viswanathan M, Carey TS, Belinson SE et al. Identifying and Managing Nonfinancial Conflicts of Interest for Systematic Reviews. Rockville, MD: Agency for Healthcare Research and Quality (US), 2013. 38. Making sense of non-financial competing interests. PLoS Med 2008;5:e199. 39. Osborne J. Arguing to learn in science: the role of collaborative, critical discourse. Science 2010;328:463–66. 40. Bekhuis T, Demner-Fushman D. Screening nonrandomized studies for medical systematic reviews: a comparative study of classifiers. Artif Intell Med 2012;55:197–207. 41. Zhou X, Wang Y, Tsafnat G, Coiera E, Bourgeois FT, Dunn AG. Citations alone were enough to predict favorable conclusions in reviews of neuraminidase inhibitors. J Clin Epidemiol 2015;68: 87–93. 42. Greenberg SA. Understanding belief using citation networks. J Eval Clin Pract 2011;17: 389–93.